In addition, the observation that the three astrocytoma progression groups differ in their frequencies of IDH1, TP53, and MUC4 mutations represents an interesting pattern that may influence the stage-wise progression of diffuse or anaplastic astrocytomas to secondary glioblastomas. The gene discussed is MUC4; the disease is astrocytoma (excluding glioblastoma).